» Articles » PMID: 35919909

NanoSIMS Combined with Fluorescence Microscopy As a Tool for Subcellular Imaging of Isotopically Labeled Platinum-based Anticancer Drugs

Overview
Journal Chem Sci
Specialty Chemistry
Date 2022 Aug 3
PMID 35919909
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-elemental, isotope selective nano-scale secondary ion mass spectrometry (NanoSIMS) combined with confocal laser-scanning microscopy was used to characterize the subcellular distribution of N-labeled cisplatin in human colon cancer cells. These analyses indicated predominant cisplatin colocalisation with sulfur-rich structures in both the nucleus and cytoplasm. Furthermore, colocalisation of platinum with phosphorus-rich chromatin regions was observed, which is consistent with its binding affinity to DNA as the generally accepted crucial target of the drug. Application of N-labeled cisplatin and subsequent measurement of the nitrogen isotopic composition and determination of the relative intensities of platinum and nitrogen associated secondary ion signals in different cellular compartments with NanoSIMS suggested partial dissociation of Pt-N bonds during the accumulation process, in particular within nucleoli at elevated cisplatin concentrations. This finding raises the question as to whether the observed intracellular dissociation of the drug has implications for the mechanism of action of cisplatin. Within the cytoplasm, platinum mainly accumulated in acidic organelles, as demonstrated by a direct combination of specific fluorescent staining, confocal laser scanning microscopy and NanoSIMS. Different processing of platinum drugs in acidic organelles might be relevant for their detoxification, as well as for their mode of action.

Citing Articles

Single Cell mass spectrometry: Towards quantification of small molecules in individual cells.

Lan Y, Zou Z, Yang Z Trends Analyt Chem. 2024; 174.

PMID: 39391010 PMC: 11465888. DOI: 10.1016/j.trac.2024.117657.


Metal-detection based techniques and their applications in metallobiology.

Zhou Y, Li H, Tse E, Sun H Chem Sci. 2024; 15(27):10264-10280.

PMID: 38994399 PMC: 11234822. DOI: 10.1039/d4sc00108g.


Increasing aggregate size reduces single-cell organic carbon incorporation by hydrogel-embedded wetland microbes.

Johnston J, Quoc B, Abrahamson B, Candry P, Ramon C, Cash K ISME Commun. 2024; 4(1):ycae086.

PMID: 38974332 PMC: 11227278. DOI: 10.1093/ismeco/ycae086.


Die Wechselwirkung mit ribosomalen Proteinen begleitet die Stressinduktion des Wirkstoffkandidaten BOLD-100/KP1339 im endoplasmatischen Retikulum.

Neuditschko B, Legin A, Baier D, Schintlmeister A, Reipert S, Wagner M Angew Chem Weinheim Bergstr Ger. 2024; 133(10):5121-5126.

PMID: 38505777 PMC: 10947255. DOI: 10.1002/ange.202015962.


Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutum.

Mayali X, Samo T, Kimbrel J, Morris M, Rolison K, Swink C Nat Commun. 2023; 14(1):5642.

PMID: 37704622 PMC: 10499878. DOI: 10.1038/s41467-023-41179-9.


References
1.
Pourahmad J, Hosseini M, Eskandari M, Shekarabi S, Daraei B . Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity. Xenobiotica. 2010; 40(11):763-71. DOI: 10.3109/00498254.2010.512093. View

2.
Crider S, Holbrook R, Franz K . Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Metallomics. 2010; 2(1):74-83. DOI: 10.1039/b916899k. View

3.
Go R, Adjei A . Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol. 1999; 17(1):409-22. DOI: 10.1200/JCO.1999.17.1.409. View

4.
van der Veer J, den Hartog J, Lohman P, Reedijk J . Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 1985; 24(3):707-13. DOI: 10.1021/bi00324a025. View

5.
Gullo J, Litterst C, Maguire P, Sikic B, Hoth D, Woolley P . Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol. 1980; 5(1):21-6. DOI: 10.1007/BF00578558. View